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Abstract
Group A streptococcus (GAS, Streptococcus pyogenes) is the cause of a variety of clinical conditions, ranging from pharyngitis
to autoimmune disease. Peptide-major histocompatibility complex class II (pMHCII) tetramers have recently emerged as a
highly sensitive means to quantify pMHCII-specific CD4
+ helper T cells and evaluate their contribution to both protective
immunity and autoimmune complications induced by specific bacterial pathogens. In lieu of identifying an
immunodominant peptide expressed by GAS, a surrogate peptide (2W) was fused to the highly expressed M1 protein
on the surface of GAS to allow in-depth analysis of the CD4
+ helper T cell response in C57BL/6 mice that express the I-A
b
MHCII molecule. Following intranasal inoculation with GAS-2W, antigen-experienced 2W:I-A
b-specific CD4
+ T cells were
identified in the nasal-associated lymphoid tissue (NALT) that produced IL-17A or IL-17A and IFN-c if infection was recurrent.
The dominant Th17 response was also dependent on the intranasal route of inoculation; intravenous or subcutaneous
inoculations produced primarily IFN-c
+ 2W:I-A
b+ CD4
+ T cells. The acquisition of IL-17A production by 2W:I-A
b-specific T cells
and the capacity of mice to survive infection depended on the innate cytokine IL-6. IL-6-deficient mice that survived
infection became long-term carriers despite the presence of abundant IFN-c-producing 2W:I-A
b-specific CD4
+ T cells. Our
results suggest that an imbalance between IL-17- and IFN-c-producing CD4
+ T cells could contribute to GAS carriage in
humans.
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Introduction
Group A streptococcus (GAS, Streptococcus pyogenes)i sa n
important bacterial pathogen that causes many different clinical
conditions ranging from pharyngitis, impetigo, toxic shock
syndrome, necrotizing fasciitis to post infectious autoimmune
sequelae like acute rheumatic fever and glomerulonephritis [1,2].
GAS is an important cause of morbidity and mortality worldwide.
Estimates are that 500,000 deaths occur each year due to severe
GAS infections [3]. GAS produces a wide variety of virulence
factors that play important roles in adhesion, immune evasion,
dissemination, tissue destruction and toxicity [1,4]. Remarkably,
one third of those treated with antibiotics continue to shed
streptococci and a significant number of these carriers have
recurrent disease by the same strain [5,6]. Carrier state is an
important public health problem because it maintains the cycle of
disease in a community. Tonsils are known to harbor and shed
streptococci, even after intense antibiotic therapy. Osterlund et al
found that 93% of tonsils excised from children retained
intracellular GAS, and others reported isolation of GAS from
excised tonsils, confirming that this secondary lymphoid tissue is
an important reservoir [7].
The capacity of GAS to survive in lymphoid tissue is not
understood. Although GAS induces a humoral immune response
in most individuals, streptococci can still persist. GAS also induces
a CD4
+ T cell response [8]. CD4
+ T cells express T cell antigen
receptors (TCR) that recognize short peptides bound to MHCII
molecules (pMHCII) expressed by host antigen-presenting cells.
During primary infection, the rare naı ¨ve CD4
+ T cells, which by
chance express TCRs complementary to bacterial pMHCII
complexes, proliferate and differentiate into Th1, Th2, or Th17
effector cells that produce cytokines such as IFN-c, IL-4 or IL-17,
respectively, which help to eliminate the pathogen. Which of these
effector cell types will develop during infection is determined by
cytokines produced by cells of the innate immune system. For
example in mice, the differentiation of Th17 cells in vitro depends
PLoS Pathogens | www.plospathogens.org 1 September 2011 | Volume 7 | Issue 9 | e1002252on IL-6 and Transforming Growth Factor-beta (TGF-b) [9]. We
recently demonstrated that GAS infection of the NALT, the murine
equivalent of the tonsils, generates Th17 cells, which contribute to
immune protection [10]. Lu et al have shown that Th17 cells protect
against other streptococcal infections as well [11].
Previous studies used adoptive transfer of monoclonal TCR
transgenic T cells to study T cell responses to infection with antigen
tagged GAS [8,12]. A drawback of this approach is that it results in
an abnormally large number of naı ¨ve precursors, which experience
inefficient activation due to competition for limiting pMHCII [13-
15]. Therefore, the nature of the CD4
+ T cell response to GAS
infection under physiological conditions is still unknown.
To avoid these limitations, we used a new cell enrichment
method based on fluorochrome-labeled pMHCII tetramers and
magnetic beads [16] to characterize the endogenous polyclonal
CD4
+ T cell response to GAS. This approach depended on the
availability of a tetramer of the I-A
b MHCII molecule of the
preferred C57BL/6 mouse strain bound to a peptide from the
GAS proteome. Unfortunately, no such peptide has been
identified to date. We therefore produced a recombinant GAS
strain that expresses an immunogenic peptide (EAWGALAN-
WAVDSA) called 2W [17] fused to the M1 protein on its surface.
2W:I-A
b tetramer staining and magnetic bead enrichment was
used to characterize 2W:I-A
b+ CD4
+ T cells from NALT and
other lymphoid tissues after intranasal GAS-2W infection. Our
results demonstrate that an intranasal infection is critical for
mounting an effective IL-6-dependent pMHCII-specific Th17
response. A lack of this response led to a preponderance of Th1
cells and failure to control GAS infection. This work defines the
Th17 response to GAS infection, and may shed light on the basis
for the carrier state and autoimmune complications in humans.
Results
Generation of recombinant GAS strain that expresses the
M1-2W fusion protein
An M1 GAS strain 90–226 was genetically engineered to
express the 14 amino acid 2W peptide (EAWGALANWAVDSA)
as a cell wall surface hybrid M1 fusion protein. The hybrid
emm1.0::2W gene was constructed in plasmid pFW5 in E. coli and
then introduced into the chromosomal emm1.0 gene by allelic
replacement [18]. The corresponding chimeric protein is com-
posed of the 14 amino acid 2W peptide inserted in frame after the
first five amino acids of the mature M1 surface protein (Fig. 1A).
The strain, designated 90–226 emm1.0::2W (GAS-2W), is
genetically stable without spectinomycin selection due to replace-
ment of the wild-type gene in the chromosome. The anti-
phagocytic property of the M1-2W fusion protein was assessed to
test whether insertion of the 2W peptide altered the function of the
M protein. GAS-2W was as resistant to phagocytosis as the wild-
type 90-226 in whole blood bactericidal assays (Fig. 1B). An M
-
variant 90-226 emm1.0::km (GAS-DM) [18] was included as a
negative control and was susceptible to phagocytic killing as
expected. Furthermore, the GAS-2W strain colonized mouse
NALT as efficiently as the wild type (Fig. 1C).
Intranasal infection with GAS-2W induced a strong
antigen-specific Th17 response in C57BL/6 mice
Spleen and lymph node cells from mice were pooled for
quantification of 2W:I-A
b-specific CD4
+ T cells by pMHCII-based
cell enrichment at various times after infection with GAS-2W.
Each C57BL/6 mouse had between 200 and 250 2W:I-A
b-specific
CD4
+ T cells before infection, and these cells expressed small
amounts of CD44 (CD44
Lo) on the surface as expected for naı ¨ve
cells (Fig. 2A) [16,19]. In mice that were inoculated intranasally
with GAS-2W, this naı ¨ve 2W:I-A
b-specific CD4
+ T cell population
expanded to ,10
5 cells in seven days (Fig. 2A). Most of these cells
expressed large amounts of CD44 (CD44
Hi), indicative of
pMHCII-dependent activation. Expansion of 2W:I-A
b-specific
CD4
+ T cells was first detected three days after primary infection
with GAS-2W and increased rapidly to a peak seven days after
inoculation (Fig. 2B). 2W:I-A
b-specific CD4
+ T cells then began to
decline and reached 10% of the maximum level by day 20-post
infection. Expansion of these CD4
+ T cells was proportional to the
dose of GAS-2W used for infection (Fig. 2C).
In vivo lymphokine production was measured by rechallenging
mice with heat-killed GAS-2W (HK-GAS-2W) and then measur-
ing intracellular lymphokines produced by 2W:I-A
b-specific T cells
3 hours later [20]. 2W:I-A
b+ cells in mice infected intranasally with
live GAS-2W one week earlier produced IL-17A, but not IFN-c
after challenge with HK-GAS-2W (Fig. 3A). 2W:I-A
b+ cells in
mice inoculated intranasally with HK-GAS-2W one week earlier
also produced IL-17A after challenge with HK-GAS-2W (Fig. 3B).
Therefore, exposure of NALT to either live or dead GAS induced
bacterial pMHCII-specific Th17 cells. In order to compare the
approximate percentage of 2W:I-A
b-specific Th17 cells to total
GAS induced Th17 cells, B6 Mice were inoculated once
intranasally with 2x10
8 CFU of GAS-2W. Ten days after the
infection mice were restimulated in vivo by IV injection of heat
killed GAS-2W. 2W:I-A
b+ CD4
+ T cells from spleen were stained
and enriched as described in the methods. Both bound (2W:I-A
b+
CD4
+ T cells) and unbound (2W:I-A
b- CD4
+ T cells or flow
through) fractions were collected and analyzed for intracellular
cytokines IL-17A and IFN-c. Total numbers of CD4
+2W:I-A
b+IL-
17A
+ and CD4
+2W:I-A
b-IL-17A
+ cells were calculated for the
entire spleen. The approximate ratio of 2W:I-A
b+IL-17A
+ cells to
total 2W:I-A
b- IL-17A
+ cells ranged from 1:7 to 1:12 (Fig S1).
Li et al reported that the Streptococcal superantigen, which
contaminates commercial peptidoglycan preparations induced
human lymphocytes to produce IL-17A [21]; therefore, experi-
ments were performed to determine whether 2W:I-A
b-specific
CD4
+ T cell clonal expansion was pMHCII-specific. B6 mice were
Author Summary
Group A streptococcus (GAS) causes many different condi-
tions, ranging from strep throat, flesh eating disease to post
infectious complications involving the heart. Here, we used a
novel technique to study the CD4
+ Tc e l li m m u n er e s p o n s e
against GAS infection in a mouse model. We first generated a
recombinant GAS strain that expresses a specific epitope
(2W) - M protein fusion and used this to intranasally inoculate
mice. Peptide specific CD4
+ T cells were concentrated and
analyzed using 2W-MHC-II tetramers. This technology
allowed us to probe the antigen specific CD4
+ T cell response
to new depths and certainty. Infection induced a robust 2W-
specific Th17 cell response, which was dependent on the
route of infection, IL-6, and was independent of superanti-
gens. IL-6
-/- mice were exquisitely susceptible to intranasal
infection. However, those that survived became immune
carriers, unable to clear streptococci from NALT. Further,
multiple infections generated an IL-17
+ IFN-c
+ double
positive population of CD4
+ Tc e l l st h a ta r ek n o w nt ob e
associated with autoimmune disease in humans and directly
responsible for autoimmune pathology in rodent models.
Our results provide a new direction for understanding two
important consequences of streptococcal pharyngitis, the
very common immune carrier state, and the rarer state
involving autoimmune complications.
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8 CFU
of GAS-2W or wild type 2W
- GAS (GAS-WT). Three days after
the last infection, mice were euthanized and enriched CD4
+2W:I-
A
b+ T cells from spleen, cervical lymph nodes (CLN), and NALT
were analyzed (Fig. 4.). Expansion of 2W:I-A
b-specific CD4
+ T
cells only occurred in mice inoculated with GAS-2W (Fig. 4A), and
not in mice inoculated with GAS-WT that lacked the 2W epitope.
The number of CD4
+2W:I-A
b+ T cells in tissue from mice infected
with GAS-WT was less than 200, similar to that of naı ¨ve mice.
This indicates that the clonal expansion of 2W:I-A
b-specific CD4
+
T cells is a pMHCII-specific response and not due to
superantigens produced by this strain of GAS (Fig. 4A). The same
samples were restimulated in vitro with pharmacologic TCR
mimics, PMA and ionomycin, and stained for intracellular
cytokines in order to evaluate their cytokine phenotype. Most of
the 2W:I-A
b-specific CD4
+ T cells from NALT, CLN and spleen
produced IL-17A (Fig. 4B); greater than 75% of the 2W:I-A
b-
specific CD4
+ T cells from all three tissues had a Th17 phenotype
(Fig. 4B). The response was more robust in NALT, which is a
preferred target of intranasal GAS infection. In NALT pMHCII-
specific IL-17A producers reached more than 90% of the total
2W:I-A
b-specific CD4
+ T cells.
Even though initial priming and expansion of CD4
+2W:I-A
b+ T
cells is independent of superantigen as shown above, it was
possible that cytokine activation in T cells from infected mice was
mediated by superantigens associated with heat-killed bacteria. To
address specificity of the recall response, B6 mice that were
inoculated twice with GAS-2W streptococci and then were
restimulated in vivo by intravenous injection of either HK-GAS-
2W or heat killed wild-type 2W
-GAS (HK-GAS-WT) bacteria.
CD4
+CD44
Hi2W:I-A
b+ cells from mice that were primed with
GAS-2W had expanded significantly, produced IL-17A 21 days
later following restimulation with HK-GAS-2W, but not with 2W
-
HK-GAS-WT bacteria (Fig. 4C). Thus both priming of CD4
+ T
cells and recall of cytokine expression by GAS is antigen-specific
and independent of superantigens in this animal model.
Children often experience multiple episodes of GAS pharyngitis
before reaching the age of 15. Therefore, we investigated whether
repeated infection amplified, shifted or dampened the Th17
response. Following multiple infections, most of the
CD4
+CD44
Hi2W:I-A
b+ T cells had elevated levels of intracellular
IL-17A (Fig.4B). The response was more robust in NALT, the
major infection site following intranasal GAS infection.
Route of inoculation influences the Th17 phenotype to
GAS infection
Recently, Pepper et al showed that the intranasal route was
important for the generation IL-17-producing 2W:I-A
b-specific T
cells in response to a recombinant strain of Listeria monocytogenes that
expressed the 2W peptide (LM-2W) [20]. Most GAS infections
naturally involve oro-pharyngeal tissue and preferably colonize
tonsils in humans and NALT in mice. Experiments were therefore
performed to assess the impact of the intranasal route of
inoculation of GAS on the CD4
+ T cell response. B6 mice were
inoculated with HK-GAS-2W intranasally, intravenously or
subcutaneously. HK-GAS-2W bacteria were used to avoid spread
of infection from the site of inoculation. 2W:I-A
b-specific T cells
expanded in the spleens of these mice in response to all routes of
inoculation. Intranasal infection with GAS-2W induced IL-17A-
producing 2W:I-A
b-specific T cells; whereas intravenous and
Figure 1. Construction of a Group A Streptococcus 90-226 strain that expresses the 2W (GAS-2W). (A) Schematic diagram of
emm1.0::2W fusion protein that is expressed on the surface of GAS-2W. SS-Signal sequence; A - A region; B - B repeats; S - spacer region; C – C
repeats; D – D region; HVR – Hyper-variable region; Cell wall anchor (466-496) (B) Survival and growth of strain GAS-2W in phagocytic human blood.
90-226 WT is the parent of GAS-2W and the M protein negative mutant GAS-DM. Fold increase was calculated as the number of CFU after 3 h in
rotated blood divided by the initial number of CFU. Representative result from one of two independent experiments is shown. (C) Colonization of
mouse NALT by intranasally administered Streptococci. Viable counts of 90-226-WT or GAS-2W streptococci recovered from homogenized NALT 24h
following inoculation with 2610
8 CFU. The bars represent the mean 6 SEM of four mice per group.
doi:10.1371/journal.ppat.1002252.g001
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The Th17/Th1 ratio was more than 40 times higher in cells from
intranasally inoculated mice compared to that from mice
inoculated intravenously or subcutaneously. Thus, the intranasal
route of infection was critical for the generation of Th17 cells
during GAS infection.
To compare the relative magnitude of Th17 induction by GAS
and LM intranasal infections, mice were inoculated either
intranasally or intravenously with either GAS-2W or LM-2W.
Intranasally both GAS-2W and LM-2W induced primarily a Th17
response. Notably, however, a larger fraction of the 2W:I-A
b-
specific T cell population produced IL-17A following intranasal
GAS-2W infection than following intranasal LM-2W infection
(Fig. 5B) [20] ; Furthermore, both GAS and LM primarily induced
a Th1 response to intravenous inoculation but LM induced a
significantly greater Th1 response than GAS (Fig. 5B). Therefore,
the PAMPs expressed by or nature of GAS infections creates an
environment more conducive to priming the Th17 phenotype
than those of LM. Moreover, these data suggest that the 2W
epitope does not influence the Th phenotype per se, since the same
naı ¨ve 2W:I-A
b-specific CD4
+ T cell population has expanded and
differentiated into different phenotypes in response to alternative
routes of infection.
IL-6-deficient mice fail to develop a Th17 response and to
clear Group A Streptococci from NALT
Although IL-6 is known to be critical for some Th17 responses
in mice, it is not known whether this is the case for streptococcal
infection. We therefore compared the primary T cell response to
GAS infection of B6 IL-6 knockout mice (IL-6
-/-) mice to age
matched wild type B6 mice, inoculated intranasally with 2x10
8 cfu
of GAS-2W. There was no significant difference in the
colonization of both groups of mice 24 hrs after inoculation with
this sublethal dose of bacteria. However, over the next 7 days
nearly a third of the IL-6
-/- mice succumbed to infection
(*P=0.0473, Logrank Test) (Fig. 6). In contrast, wild-type B6 mice
had no casualties and most had reduced their bacterial load in
NALT. IL-6
-/- mice that survived infection continued to harbor
high bacterial counts for up to 60 days; whereas, all wild-type mice
completely cleared the bacteria from NALT by day 7.
IL-6
-/- mice that survived the first week of infection returned to
health even though they retained significant numbers of GAS-2W
organisms in NALT. T cells from both wild-type and IL-6
-/- mice
were restimulated in vivo after one week by intravenous injection of
HK-GAS-2W. The 2W:I-A
b+ cells from IL-6
-/- mice (Fig. 6A) had
proliferated in response to infection with GAS-2W streptococci but
failed to produce IL-17A. Instead, many of these cells produced
IFN-c (Fig. 6A). These results confirm that IL-6 is required to
promote a Th17 response after GAS infection. Long-term
persistence of GAS-2W in NALT from IL-6
-/- mice is consistent
with the possibility that clearance from NALT and perhaps human
tonsils requires a vigorous Th17 adaptive response and that IFN-
c
+ T cells lack potential to eliminate streptococci from lymphoid
tissue.
Recurrent GAS infection shifts the antigen-specific
population toward an IL-17A
+ IFN-c
+ double positive
phenotype in NALT
The Th17 phenotype is less stable than the Th1 phenotype
[20,22,23]. For example, IL-17A
+ T cells were observed to acquire
Figure 2. 2W:I-A
b-specific naı ¨ve CD4
+ T cells expanded in response to intranasal infection with GAS-2W. (A) B6 mice were infected with
GAS-2W (intranasal, 2610
8 CFU). Seven days later CD4
+2W:I-A
b+ cells were enriched from cervical lymph nodes and spleens and analyzed by flow
cytometry. One representative of at least ten independent experiments is shown. CD44 indicates the number of antigen experienced CD4
+ T cells (B)
Change in the total number of 2W:I-A
b-specific CD4
+ T cells after a primary infection over time (n=28). (C) Mean number of antigen specific
CD4
+2W:I-A
b+ T cells is dose dependent. B6 mice were inoculated intranasally with 2610
8,4 610
7 and 8610
6 CFU/mouse, respectively. Seven days
after infection CD4
+2W:I-A
b+ cells were isolated from cervical lymph nodes and spleen, and analyzed.
doi:10.1371/journal.ppat.1002252.g002
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environment [24]. The regulatory program and precursor to these
double positive T cells is unclear, as is the impact of infection on
this phenotype. These considerations prompted experiments to
test the influence of multiple intranasal infections on the Th17
population in NALT. Wild-type B6 mice usually clear GAS from
NALT 5-7 days after an intranasal inoculation [25]. For recurrent
infection, B6 mice were inoculated intranasally with 2610
8 GAS-
2W CFU at weekly intervals for 12 weeks. One week after the last
inoculation cells were harvested from NALT, CLN and spleen,
activated in vitro with PMA and ionomycin, and analyzed for
intracellular cytokines IL-17A and IFN-c. After repeated exposure
to GAS-2W, IL-17A
+ IFN-c
+ 2W:I-A
b-specific CD4
+ cells
preferentially accumulated in the NALT, whereas the primary
phenotype of CD4
+CD44
Hi2W:I-A
b+ cells in spleen and CLN
from the same mice retained a Th17 phenotype (Fig. 7A and 7B).
More than 60% of CD4
+CD44
Hi2W:I-A
b+ cells were positive for
both cytokines; whereas, fewer than 12% from spleens and cervical
lymph nodes were double positive. The implications of this change
will be discussed below.
Discussion
We recently discovered that GAS induces a polyclonal, TGF-b1
dependent Th17 response in intranasally infected mice. Moreover,
adoptive transfer of CD4
+ IL-17A
+ T cells imparted partial
protection to naı ¨ve mice against intranasal infection. That
investigation raised several questions, which could be more
definitively answered using pMHCII tetramers to quantify antigen
specific T cells that recognize a streptococcal expressed antigen. In
lieu of identifying immunodominant bacterial specific T cell
epitopes, the surrogate 14 amino acid peptide 2W was fused to M1
protein and expressed on the streptococcal surface. The
recombinant serotype M1 strain, GAS-2W, was constructed and
M protein function confirmed by phagocytosis assays using human
blood. Moreover, the GAS-2W strain colonized mouse NALT as
efficiently as wild type 90-226 streptococci.
For unknown reasons, humans often fail to develop protective
immunity after a single episode of pharyngitis or tonsillitis, and
persistence of GAS in tonsils even after antibiotic intervention is
common [7]. This problem could be explained by failure to
develop a sufficient Th17 immune response. However, we found
that a single intranasal infection with GAS-2W rapidly induced a
robust 2W:I-A
b-specific Th17 population, which paralleled the
clearance of bacteria in mice. The 2W:I-A
b-specific Th17
population represented ,10% of the total GAS specific Th17
induced (Fig. S1). Superantigens are powerful mitogens that
induce massive TCR V beta chain-specific clonal expansion of T
cells. Group A streptococci, including the GAS-2W strain are
known to produce many superantigens, which have been
implicated in highly lethal streptococcal toxic shock and
autoimmune sequelae [1,26]. Such superantigens do not account
for the expansion of 2W:I-A
b-specific CD4
+ T cells following
Figure 3. Primary intranasal GAS infection induces a Th17 response. Mice were inoculated once intranasally with 2610
8 CFU or equivalent
numbers of heat-killed streptococci HK-GAS. (A) CD4
+CD44
Hi2W:I-A
b+ cells enriched from spleens of mice that were inoculated with live GAS-2W and
restimulated after a week in vivo by IV injection of heat killed GAS-2W (HK-GAS-2W). (B) CD4
+CD44
Hi2W:I-A
b+ cells from mice that were inoculated
intranasally with heat-killed GAS-2W and restimulated in vivo with HK-GAS-2W. One representative of three independent experiments is shown.
doi:10.1371/journal.ppat.1002252.g003
Antigen Specific CD4 T Cell Response to S.pyogenes
PLoS Pathogens | www.plospathogens.org 5 September 2011 | Volume 7 | Issue 9 | e1002252GAS-2W infection, despite the fact that some of these T cells
express the relevant TCR V beta chains [19]. This conclusion may
not reflect the situation during human infections because murine
T cells are known to be relatively refractory to bacterial
superantigens. Dominance of the Th17 response to GAS is
impressive relative to that observed for other bacterial pathogens
like Listeria. After a single infection 20-39% of the 2W-specific T
cells produced IL-17A. By comparison, only about 5–12% of
2W:I-A
b-specific CD4
+ cells produced IL-17A in response to
primary LM-2W intranasal infection (Fig. 5, [20]). Furthermore,
both GAS and LM primarily induced a Th1 response to
intravenous inoculation and as expected LM induced a more
robust Th1 response than GAS (Fig. 5B). Therefore, GAS might
have other features that make for more efficient Th17 induction
than LM. Furthermore, these results suggest that the 2W epitope
per se does not influence the out come of the CD4
+ T cell
response. The more robust Th17 response could reflect the GAS
tropism for NALT [8] and human tonsils [4], the potential for
these bacteria to induce TGF-b1 production in these sites [10],
expression of a unique pathogen-associated molecular patterns
(PAMPs), or a combination of these factors. GAS was shown to
induce TGF-b1 and IL-6 in NALT [10], but the specific PAMPs
that lead to expression of these cytokines are unknown. The
substantial hyaluronic acid capsule or its degradation products are
known to induce TLR2- and TLR4-mediated inflammation
[27,28], and TLR2 agonists are known to promote Th17
differentiation [29]. M1 protein is also a TLR2 agonist [30] and
known to induce inflammatory cytokines, including IL-6 [31] and
TGF-b1 [32], and is, therefore, another potential PAMP that
could direct a Th17 response. The finding that intranasal
inoculation, even with heat-killed GAS-2W cells induces an
antigen-specific Th17 response, while other routes induce a Th1
Figure 4. Clonal expansion of 2W:I-A
b-specific CD4
+ T cells and recall of IL-17A is antigen-specific and not due to Superantigens
produced by GAS. (A) Tetramer enriched CD4
+ T cells from Spleen, CLN and NALT of mice after three inoculations at weekly intervals. Top panel is
from wild type GAS (GAS-WT) infected B6 mice and the lower panel is from B6 mice inoculated with (GAS-2W). (B) Analysis of IL-17A expression by
CD4
+ CD44
Hi 2W:I-A
b-specific T cells in NALT, CLN and Spleen from the lower panel of part A. (C) Analysis of the specificity of IL-17A activation in CD4
+
2W:I-A
b+ T cells originally primed by GAS-2W infection (twice). Primed mice were restimulated in vivo by IV injection of heat killed GAS-2W (HK-GAS-
2W) or heat killed 2W negative GAS (HK-GAS-WT) 21 days after the last infection. CD4
+CD44
Hi2W:I-A
b+ cells were isolated as described in methods and
analyzed for IL-17A and IFN-c expression.
doi:10.1371/journal.ppat.1002252.g004
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delivery of vaccines to protect against GAS and other mucosal
pathogens. The pathogenic potential of IL-17A
+ T cells and their
short half-life questions the potential safety and utility of intranasal
vaccines.
We previously observed that single cell suspensions of NALT,
spleen, and cervical lymph nodes from intranasally infected mice
secrete TGF-b1, IL-6 and IL-17 upon ex vivo restimulation [10].
Although IL-17 secretion was dependent on TGF-b1 receptor
signals, dependence on IL-6 was not tested. As predicted [33], IL-
6
-/- mice failed to mount a Th17 response and instead developed
IFN-c
+ T cells following intranasal infection. As reported by Diao
et al, we found high mortality in IL-6
-/- mice infected with GAS
[34], perhaps as a consequence of exuberant TNF-a expression.
Nearly a third of IL-6
-/- mice, inoculated intranasally, developed
lethal systemic infections; however, survivors fully recovered
without subsequently developing systemic infections even though
they retained large numbers of GAS in NALT (Fig. 6). This
suggests that protection is compartmentalized, ie. opsonic
antibody is required to clear bacteria from blood, but does not
efficiently remove them from NALT or tonsils. On the other hand
a robust Th17 cellular response would be required to eliminate
streptococci from those lymphoid organs. Secretory antibody that
baths mucosal surfaces may also protect against pharyngitis, but
may not be able to reach bacteria sequestered within NALT.
These findings are also consistent with studies of Th17 protection
induced by intranasal infections of mice with encapsulated S.
pneumoniae [11]. It is theoretically possible that local activation of
antigen specific T cells could recruit phagocytes with potential to
ingest other unrelated bacteria at that site, but recruitment of
phagocytes to those infectious foci would still be antigen specific.
In addition, IL-6
-/- mice developed a robust antigen specific Th1
response (Fig. 6) but failed to clear the bacteria from NALT. This
finding is consistent with the observation that IFN-c
-/- mice [35]
cleared streptococci from NALT more rapidly than normal mice.
We postulate that efficient elimination of GAS depends on IL-17A
production by Streptococcal specific CD4
+ T cells to attract
neutrophils to infected NALT, a capacity that IFN-c-producing T
Figure 5. Route of inoculation determines the Th17 phenotype to GAS infection. (A) B6 mice were inoculated intranasally (I/N),
intravenously (I/V) or subcutaneously (S/C) with HK-GAS-2W. After one week mice were restimulated in vivo with HK-GAS-2W for 4 hours and then
CD4
+CD44
Hi2W:I-A
b+ cells from spleen were stained for cytokines IL-17A and IFN-c and analyzed by flow cytometry. (B) Comparison of the
CD4
+CD44
Hi2W:I-A
b+ T cell response to GAS-2W or Listeria monocytogenes (LM-2W) intranasal and intravenous infections. Three weeks after a single
intranasal or intravenous inoculation with bacteria, single cell suspensions from spleens were incubated with PMA and ionomycin for 4 hrs.
CD4
+CD44
Hi2W:I-A
b+ cells were then enriched, stained and analyzed for IL-17A and IFN-c expression by flow cytometry. (n=7-12 mice per group). The
bars represent the mean 6 SEM. *= P,0.002, ** = P,0.001, Mann Whitney test.
doi:10.1371/journal.ppat.1002252.g005
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-/-
mice is reminiscent of the situation in human immune carriers who
may also fail to develop an adequate Th17 response.
The Th17 response is known to contribute to immune
protection against infections by several pathogens [10,11,
36,37,38]; however, these T cells can also be pathogenic, as
demonstrated in murine autoimmune models, such as experimen-
tal encephalomyelitis (EAE) [39,40]. A potentially important
discovery from our experiments is that repeated intranasal
exposure to GAS-2W results in the accumulation of an IL-17A
+
IFN-c
+ (double positive) 2W:I-A
b-specific CD4
+ T cells in NALT.
In contrast, 2W:I-A
b-specific CD4
+ T cells in CLN and spleens
from the same mice predominantly retained the Th17 phenotype.
Preferential accumulation of double positive T cells in NALT
could be explained by a unique homing potential, by more rapid
expansion or a longer half-life of double positive cells relative to
those only able to produce IL-17A. Whether the large population
of antigen-specific IL-17
+ IFN-c
+ double positive cells observed in
NALT following recurrent GAS infection is associated with an
autoimmune response is unknown: however, repeated intranasal
infection of mice was reported to occasionally produce endocar-
ditis and valvular lesions[41], suggesting a link to human
autoimmune disease.
Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
animal experiments were conducted under University of Minne-
sota Institutional Animal Care and Use Committee (IACUC)
approved protocol number 0806A36362.
Bacterial strains and growth
Streptococci were grown in Todd-Hewitt broth supplemented
with 2% neopeptone (THB-Neo) or on solid media containing
Difco blood agar base and sheep blood at 37uCi n5 %C O 2. All
growth media were purchased from Difco Laboratories, Detroit,
MI. Strain 90–226 (serotype M1) was originally isolated from the
blood of a septic patient [18].
Mice
Five to six weeks old female C57BL/6 mice were purchased
from Taconic farms (Germantown, NY) and used at 7–8 weeks of
age. IL-6
-/- mice in C57BL/6 background were purchased from
the Jackson Laboratory (Bar Harbor, ME) [42]. Mice were housed
under specific pathogen-free conditions at RAR facilities of
University of Minnesota. Mice inoculated with GAS were housed
in biosafety level 2 facilities.
Generation of a recombinant GAS strain that expresses
the 2W epitope in M protein
An M1 GAS strain 90–226 was genetically engineered to
express the 14 amino acid 2W peptide (EAWGALANWAVDSA)
on the bacterial surface as a fusion protein with streptococcal M
protein (Fig. 1). The corresponding chimeric protein is composed
of the 2W epitope inserted in-frame after the first five amino acids
of the mature M1 surface protein. The hybrid emm1.0::2W gene
was constructed using standard molecular biology techniques and
then introduced into the chromosomal emm1.0 gene locus by
allelic replacement. Briefly, the emm1.0 gene of strain 90–226 is
contiguous with mga at the 59 end and with the sic gene at the 39
end, and has its own promoter. Plasmid pFW5 has two multiple
cloning sites on either side of a spectinomycin resistance gene
[8,18]. The entire sic gene with its promoter was PCR amplified
and inserted into the multiple cloning site downstream of the
spectinomycin resistance gene in pFW5. A fragment containing
the C-terminal half of mga through the entire emm1.0 gene was
PCR amplified by a two-step method to insert the sequence of the
2W epitope into the emm1.0 gene. In the first step, DNA
fragments, each coding for part of the 2W epitope sequence
(overlapping) were amplified by PCR. In the second step these
overlapping fragments were annealed, extended and further
amplified to generate a 2.5-kb fragment, which was inserted into
the multiple cloning site upstream of the spectinomycin resistance
gene in pFW5. This plasmid was transformed into strain 90–226
emm1.0::km for gene replacement, and transformants were
Figure 6. Mice deficient in Th17 cells fail to clear primary GAS
infections from NALT and become chronic carriers. (A) Analysis
of IL-17A and IFN-c expression of CD4
+CD44
Hi2W:I-A
b+ T cells from IL-6
knockout mice (IL-6
-/-) infected with GAS-2W. CD4
+CD44
Hi2W:I-A
b+ cells
were enriched from spleens of IL-6
-/- mice that were intranasally
inoculated with HK-GAS-2W and restimulated in vivo after a week by IV
injection of HK-GAS-2W. (B) Comparison of IL-6
-/- mice (n=17) to age
matched wild type B6 mice (n=14) for susceptibility to intranasal GAS
infection. Mice were inoculated with 2610
8 CFU/mouse intranasally.
Mice were euthanized at different time points after inoculation and CFU
associated with NALT were assessed. Data are presented as mean CFU
6 SEM. (C) Kaplan-Meier survival curve of IL-6
-/- and WT-B6 mice
(*P,0.04, Logrank Test.)
doi:10.1371/journal.ppat.1002252.g006
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resistant transformants were then screened for kanamycin
sensitivity. Positive clones (Spec
RKan
S) were screened for gene
replacement and the entire region including the 2W insertion was
amplified and sequence verified. The resulting strain was
designated Streptococcus pyogenes 90-226 emm1.0::2W (GAS-2W).
A whole blood phagocytosis assay was used to test whether GAS-
2W streptococci are M
+ [43].
Intranasal inoculation
C57BL/6 mice were anesthetized with isoflurane/oxygen
mixture for 1 min and inoculated intranasally with GAS-2W by
placing appropriate doses in a total volume of 15 ml PBS (7.5 ml/
nostril). Fractionated droplets were placed with a pipette tip near
the entrance of the nostril and the inoculum was involuntarily
aspirated into the nasal cavity.
In vitro stimulation with PMA-ionomycin
NALT, Cervical lymph nodes (CLN) and Spleen from C57BL/
6 mice were harvested by dissection, disrupted on a nylon screen
in 1–2 ml of complete EHAA medium (cEHAA). Resulting single
cell suspensions were filtered over a nylon screen and washed with
cEHAA before invitro stimulation and staining. Freshly made
single cell suspensions in cEHAA were stimulated in vitro with
PMA and ionomycin for 4 hours. PMA and ionomycin were
added at 50 ng/ml and 500 ng/ml final concentrations, respec-
tively. Cells were incubated at 37C for 1 hour and Brefeldin A
(BrA) was added to disrupt golgi and prevent cytokines from being
secreted into the medium (1:1000 of 10 mg/ml DMSO stock) and
incubated for three additional hours before proceeding to tetramer
enrichment.
Tetramer production
2W:I-A
b tetramers were generated as described in detail by
Moon et al [16,19]. Briefly, 2W:I-A
b was expressed in S2 cells. S2
cells were co-transfected with plasmids encoding the I-A
b alpha
chain, the I-A
b beta chain and BirA gene. Transfected cells were
selected, passaged in serum-free media, and cultures scaled up to
one liter cultures. Expression was induced with copper sulfate and
biotinylated 2W:I-A
b heterodimers were purified from superna-
tants with a Ni
++ affinity column. Bound 2W:I-A
b molecules were
eluted and purified. Tetramers were created by mixing biotiny-
lated 2W:I-A
b molecules with Phycoerythrin (PE) or Allophyco-
cyanin (APC)-conjugated streptavidin.
Peptide-MHC-II tetramer based magnetic bead
enrichment
2W:I-A
b-specific CD4
+ T cells were enriched as described
previously [16,19,20]. Briefly mice were euthanized and NALT,
cervical lymph nodes and Spleen were harvested separately. Single
Figure 7. Recurrent GAS infection shifts the cytokine profile of CD4
+ 2W:I-A
b+ T cells to IL-17A
+, IFN-c
+ population in NALT. (A) B6
mice were inoculated intranasally with 2610
8 CFU at weekly intervals for 12 weeks. CD4
+CD44
Hi2W:I-A
b+ T cells from Spleens, CLNs and NALT of
infected mice were restimulated in vitro with PMA and ionomycin, stained and analyzed for IL-17A and IFN-c and analyzed by flow cytometry.
Representative result from one of two independent experiments is shown. (B) Pooled results of two independent experiments shown. (n=4).
doi:10.1371/journal.ppat.1002252.g007
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from 2.4G2 hybridoma cells grown in serum-free media + 2%
mouse serum, 2% rat serum, 0.1% sodium azide) from each tissue.
Phycoerythrin (PE) or Allophycocyanin (APC) conjugated tetra-
mer was added at a final concentration of 10 nM and the cells
were incubated at room temperature for 1 hr, followed by a wash
in 15 ml of ice-cold FACS buffer (PBS + 2% fetal bovine serum,
0.1% sodium azide). The tetramer-stained cells were then
resuspended in a volume of 200 ml of FACS buffer and mixed
with 50 ml of anti-PE or anti-APC antibody conjugated magnetic
microbeads (Miltenyi Biotech, Auburn, CA) and incubated on ice
in dark for 30 min, followed by one wash with 10 ml of FACS
buffer. The cells were resuspended in 3 ml of FACS buffer and
passed over a magnetized LS column (Miltenyi Biotech). The
column was washed with 3 ml of FACS buffer three times and
then removed from the magnetic field. The bound cells were
eluted by pushing 5 ml of FACS buffer through the column with a
plunger. The resulting enriched fractions were resuspended in
0.1 ml of FACS buffer, and a small volume was removed for cell
counting while the rest of the sample was stained with a cocktail of
fluorochrome-labeled antibodies.
In vivo stimulation with heat-killed GAS-2W
GAS-2W was grown in THB-Neo media to O.D.600 of 0.5,
washed once with PBS, pelleted and resuspended in appropriate
volume of PBS and incubated at 60C for 30 minutes. Viability of
bacteria was confirmed by plating out on blood agar plates. Heat-
killed GAS-2W was stored in aliquots at -20C until use. To induce
cytokine production by 2W:I-A
b-specific CD4
+ T cells in vivo, 2 X
10
8 CFU heat-killed GAS-2W in 200 ml of PBS was inoculated
intravenously through tail vein. Mice were sacrificed after 3–4 hrs
and single cell suspensions of spleen were made in cEHAA
medium supplemented with BrA.
Intracellular cytokine staining
Intracellular cytokine staining for IL-17A and IFN-c was done
using BD Cytofix/Cytoperm fixation-permeabilization solution
and anti-IL-17A-PE and anti-IFN-c-PE-Cy7 antibodies according
to manufacturer’s protocols. Briefly cells stimulated in vivo with
heat-killed GAS-2W or in vitro with PMA-ionomycin were
subjected to 2W-MHCII tetramer enrichment. Enriched cells
were stained for surface markers, washed and fixed with 250 mlo f
Fixation/Permeabilization solution (BD Biosciences) per sample
for 20 min on ice. All samples were washed with 1 ml of 1X
Perm/Wash buffer (BD Biosciences) and anti IL-17A PE and anti
IFN-c-PE-Cy7 antibodies were added in 100 ml of 1X Perm/
Wash buffer and incubated overnight at 4C in dark. The following
day cells were washed with 1 ml of 1X Perm/Wash buffer and
resuspended in 400 ml of FACS buffer and transferred to a micro
tube within a FACS tube for analysis in LSR-II flow cytometer.
Flow cytometry and antibodies
A Becton Dickinson LSR-II flow cytometer was used to collect
and analyze events that have the light scatter properties of
lymphocytes and are CD4
+ and 2W:I-A
b+. Pacific Blue-conjugated
anti-B220, CD11b, F4/80 (Caltag), CD11c (eBioscience, San
Diego, CA); Pacific Orange-conjugated CD8 (eBioscience);
PerCP-conjugated CD4 (BD PharMingen); PE-Cy7-conjugated
IFN-c (eBioscience); PE conjugated IL-17A; APC-AF780 conju-
gated CD4 and AlexaFluor 700-conjugated CD44 (eBioscience);
PE-conjugated CD4; FITC-conjugated CD4; PB-conjugated
CD4; APC-conjugated CD4; AF700-conjugated CD4; PerCP-
Cy5.5-conjugated CD4; APC-AF750-conjugated CD4. Antibodies
were purchased from the indicated sources. FACS acquisition was
performed using FACSDiva software and analysis was done using
FlowJo (Tree Star, Ashland, OR).
Statistics
All values are expressed as mean 6 SEM. Differences between
groups were analyzed using Student’s t-test by GraphPad Prism
(Version 4.03 for Windows, GraphPad Software, San Diego, CA).
Differences are considered significant at P,0.05.
Supporting Information
Figure S1 Primary intranasal GAS infection induces a
Th17 response in both 2W:I-A
b+ and 2W:I-A
b- CD4
+ T cell
populations. B6 Mice were inoculated once intranasally with
2610
8 CFU of GAS-2W. 10 days after the infection mice were
restimulated in vivo with IV injection of heat killed GAS-2W.
2W:I-A
b+ CD4
+ T cells from spleen were enriched on magnetized
columns. Both bound and unbound fractions were collected and
analyzed for intracellular cytokines IL-17A and IFN-c. Upper
panel shows the bound fraction and cells shown in the middle and
right columns are gated on CD4
+CD44
Hi cells. Lower panels
shows the unbound (flow through) fraction. One representative of
two independent experiments is shown. Numbers of CD4
+IL-17A
+
T cells shown in the quadrants above were calculated for the
whole spleen. The approximate ratio of 2W:I-A
b+IL-17A
+ cells to
streptococcus activated total 2W:I-A
b- IL-17A
+ cells ranged from
1:7 to 1:12.
(TIF)
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